Francesco Cosentino

Professor of Cardiology

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Nikolaus Marx

GERMANY

View details

Philip Newsome

University of Birmingham

UNITED KINGDOM

View details

David A. Hess

University of Toronto

CANADA

View details

Ann Marie Schmidt

New York University Grossman School of Medicine

UNITED STATES

View details

Deepak Bhatt

Director of Mount Sinai Heart and Dr. Valentin Fuster Professor of Cardiovascular Medicine

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Chiara Fraccaro

ITALY

View details

Darren McGuire

Distinguished Teaching Professor

University of Texas Southwestern Medical School

UNITED STATES

View details

Subodh Verma

University of Toronto

CANADA

View details

Antonio Ceriello

Head of Dept.

ITALY

View details

Lars H Lund

Karolinska University Hospital

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francesco Cosentino

Research Interests

Explore related searches

Contact this professor

Articles (16)

The year in cardiovascular medicine 2023: the top 10 papers in diabetes and metabolic disorders

Cardio‐renal‐metabolic disease in primary care setting

Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial

Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes: data from the Swedish Heart Failure and Swedish National Diabetes Registries

Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table.

Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction

Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV

Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease

The year in cardiovascular medicine 2022: the top 10 papers in diabetes and metabolic disorders

Cardiometabolic disease: linking pathogenic mechanisms to therapeutic opportunities

Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial

Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis

Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry

Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial

Emerging role for SGLT2 inhibitors in mitigating the risk of hyperkalaemia in heart failure

Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease

Collaborators (10)

Nikolaus Marx

Philip Newsome

David A. Hess

Ann Marie Schmidt

Deepak Bhatt

Chiara Fraccaro

Darren McGuire

Subodh Verma

Antonio Ceriello

Lars H Lund

Make your next move.